Of note, systemic and cutaneous ALCL lacking any of these chromosomal translocations and the related constitutively active fusion kinases, frequently display activating point mutations of JAK1, JAK3, and/or STAT3 (37). This evidence concerns the gene STAT3 and anaplastic large cell lymphoma.